Carmell Therapeutics (CTCX) via Alpha Healthcare Acq III (ALPA) deck

Carmell Therapeutics is a Phase 2 stage biotechnology platform company developing allogeneic plasma-based biomaterials that are designed to boost innate regenerative pathways across a variety of bone and soft tissue indications.

Debarshi Ghosh

This post is for subscribers only


Already have an account? Log in